These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16419427)

  • 21. Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation.
    Busca A; Saroglia EM; Lanino E; Manfredini L; Uderzo C; Nicolini B; Messina C; Rabusin M; Miniero R
    Bone Marrow Transplant; 2000 May; 25(10):1067-71. PubMed ID: 10828867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantation.
    Bacigalupo A; Vitale V; Corvò R; Barra S; Lamparelli T; Gualandi F; Mordini N; Berisso G; Bregante S; Raiola AM; Van Lint MT; Frassoni F
    Br J Haematol; 2000 Jan; 108(1):99-104. PubMed ID: 10651732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late CD8+ lymphocytic alveolitis after allogeneic bone marrow transplantation and chronic graft-versus-host disease.
    Leblond V; Zouabi H; Sutton L; Guillon JM; Mayaud CM; Similowski T; Beigelman C; Autran B
    Am J Respir Crit Care Med; 1994 Oct; 150(4):1056-61. PubMed ID: 7921436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation.
    Karwacka E; Ołdakowska-Jedynak U; Brydak-Godowska J; Paczek L; Kecik D
    Transplant Proc; 2006; 38(1):292-4. PubMed ID: 16504728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.
    Mehta J; Powles R; Singhal S; Iveson T; Treleaven J; Catovsky D
    Bone Marrow Transplant; 1996 Mar; 17(3):371-5. PubMed ID: 8704689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
    J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
    Mehta J; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Middleton G; Eisen T; Singhal S
    Bone Marrow Transplant; 1996 Oct; 18(4):741-6. PubMed ID: 8899189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of chronic graft-versus-host-disease following allogeneic peripheral blood stem cell rescue for poor graft function after bone marrow transplantation.
    Kim HJ; Chung IJ; Lee JJ; Seo JS; Park MR; Choi KS; Kook H; Hwang TJ
    Korean J Intern Med; 1998 Feb; 13(1):60-3. PubMed ID: 9538634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antileukemic effects of rapid cyclosporin withdrawal in patients with relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation.
    Brandenburg U; Gottlieb D; Bradstock K
    Leuk Lymphoma; 1998 Nov; 31(5-6):545-50. PubMed ID: 9922044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Encouraging preliminary results in 12 patients with high-risk haematological malignancies by omitting graft-versus-host disease prophylaxis after allogeneic transplantation.
    Fassas AB; Rapoport AP; Cottler-Fox M; Chen T; Tricot G
    Br J Haematol; 2000 Nov; 111(2):662-7. PubMed ID: 11122119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute exacerbation of ocular graft-versus-host disease and anterior uveitis after COVID-19 vaccination.
    Lin CY; Chien HJ
    BMC Ophthalmol; 2023 Aug; 23(1):360. PubMed ID: 37596535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation.
    Rosenbeck LL; Kiel PJ; Kalsekar I; Vargo C; Baute J; Sullivan CK; Wood L; Abdelqader S; Schwartz J; Srivastava S; Abonour R; Robertson MJ; Nelson RP; Cornetta K; Fausel CA; Farag SS
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):916-22. PubMed ID: 20932925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orthoclone OKT3 for graft failure after allogeneic bone marrow transplantation: a case report.
    Yen CC; Chen PM; Chiou TJ; Hsieh RK
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Feb; 59(2):126-31. PubMed ID: 9175303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (ECP).
    Gerber M; Gmeinhart B; Volc-Platzer B; Kalhs P; Greinix H; Knobler R
    Bone Marrow Transplant; 1997 Mar; 19(5):517-9. PubMed ID: 9052923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Graft-versus-host disease: Review of 22 cases].
    Steels E; Meuleman N; Vereecken P; de Saint Aubain N; De Dobbeleer G; Bron D; Heenen M
    Acta Clin Belg; 2004; 59(4):182-8. PubMed ID: 15597724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strong antileukemic effect of chronic graft-versus-host disease in allogeneic marrow transplant recipients having acute leukemia treated with methotrexate and cyclosporine. The Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Labopin M; Gluckman E; Reiffers J; Vernant JP; Jouet JP; Harousseau JL; Fiere D; Bacigalupo A; Frassoni F; Gorin NC
    Transplant Proc; 1997; 29(1-2):733-4. PubMed ID: 9123501
    [No Abstract]   [Full Text] [Related]  

  • 37. Improvement in outcome for children receiving allogeneic bone marrow transplantation in first remission of acute myeloid leukemia: a report from the Groupe d'Etude des Greffes de Moelle Osseuse.
    Michel G; Gluckman E; Blaise D; Esperou-Bourdeau H; Vernant JP; Kuentz M; Bordigoni P; Milpied N; Rubie H; Thuret I
    J Clin Oncol; 1992 Dec; 10(12):1865-9. PubMed ID: 1453201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic graft-versus-host disease resembling acute hepatitis: additional treatment with ursodeoxycholic acid.
    Chiba T; Yokosuka O; Kanda T; Fukai K; Imazeki F; Saisho H; Nishimura M; Saito Y
    Liver; 2002 Dec; 22(6):514-7. PubMed ID: 12445178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypereosinophilia as a presenting sign of acute graft-versus-host disease after allogeneic bone marrow transplantation.
    McNeel D; Rubio MT; Damaj G; Emile JF; Belanger C; Varet B; Brousse N; Hermine O; Buzyn A
    Transplantation; 2002 Dec; 74(12):1797-800. PubMed ID: 12499902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment with steroids of upper gastrointestinal acute graft vs. host disease after hematopoietic stem cell transplantation.
    Nishi T; Okazaki K; Fujii S; Uchida K; Uose S; Nakase H; Ohana M; Nishihara T; Chiba T
    Endoscopy; 2001 Nov; 33(11):985-7. PubMed ID: 11668409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.